RecruitingPhase 4NCT05108818

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults


Sponsor

University of Pennsylvania

Enrollment

700 participants

Start Date

Oct 7, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in immune responses, participants with various years of birth will be enrolled. The investigators hypothesize that humans with different birth years will mount antibody and cellular responses of different specificities following seasonal influenza vaccination.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines how the immune system responds to the annual influenza (flu) vaccine in healthy adults. Researchers will collect blood samples before and after vaccination to measure antibody levels and immune cell activity, aiming to understand what makes some people respond to the vaccine better than others. You may be eligible if: • You are 18 years of age or older • You are in good health based on a self-reported health survey • You are willing and able to attend all study visits You may NOT be eligible if: • You have a known allergy to the flu vaccine ingredients or latex • You have had a severe reaction to a previous flu vaccine • You have a history of Guillain-Barré syndrome within 6 weeks of receiving a flu vaccine • You are immunosuppressed due to illness or treatment (including chemotherapy in the past 36 months) • You are pregnant • You have known HIV, hepatitis B, or hepatitis C infection • You have received an influenza vaccine in the past 2 months • You received immunoglobulin or a blood product in the past 3 months • You have active cancer currently being treated • You are currently taking long-term steroids Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALSeasonal influenza vaccine

The seasonal influenza vaccine is administered intramuscularly at a dose of 15 ug of HA per component, as approved by the FDA.


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05108818


Related Trials